Tetraphase Pharmaceuticals to Participate at Upcoming

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
84
Tetraphase Pharmaceuticals to Participate at Upcoming Investor Conferences

WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that company management will participate at the following upcoming investor conferences:

  • B. Riley FBR Healthcare Conference and Panel Discussion: “ Vaccines and antibiotics can't be developed for intractable infectious diseases” (Track 1: The Great Debates: Controversies in Biotech) on Tuesday, September 4, 2018 at 1:55 p.m. Eastern Time at the New York Marriott East Side Hotel in New York City.  
  • H. C. Wainwright 20 th Annual Global Investment Conference on Wednesday, September 5, 2018 at 12:30 p.m. Eastern Time at the St. Regis Hotel in New York City.

A live audio webcast of the H. C. Wainwright presentation will be available on the company’s website at http://ir.tphase.com/events.cfm . The archived presentation will be available for 30 days.

About Tetraphase Pharmaceuticals, Inc. Tetraphase is a biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections, including those caused by many of the multidrug-resistant bacteria highlighted as urgent public health threats by the World Health Organization and Centers for Disease Control and Prevention. The Company has created more than 3,000 novel tetracycline compounds using its proprietary technology platform. Tetraphase's pipeline includes three antibiotic clinical candidates: eravacycline, TP-271 and TP-6076. Eravacycline has completed phase 3 clinical testing and is under review for potential approval in cIAI by the U.S. Food and Drug Administration, with a Prescription Drug User Fee Act date of August 28, 2018 and has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency. TP-271 and TP-6076 are in phase 1 clinical trials. Please visit www.tphase.com for more company information.

Media and Investor Contact: Tetraphase Pharmaceuticals Jennifer Viera 617-600-7040 jviera@tphase.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alliant's Ritchie Earns Titan 100 Honor—A Leader's Impact

Updated Category News Views 52

Ritchie's Recognition: An Ongoing Leadership Journey When leadership is genuine, it resonates through the ranks all the way to the community. That's exactly what Meredith Ritchie, EVP at Alliant Credit Union, has been doing—and it shows as she nabs the Chicago Titan 100 accolade yet again in 2027. These folks at Titan 100 don’t hand out participation trophies;...

Continue Reading
Newsday Unveils Essential Guide to NY Colleges

Updated Category News Views 56

Launching a Comprehensive College Resource Ah, the college decision stress. Back in the day it was simpler, just pick a campus that looked good on paper and hope for the best. But now? Kids and their families have got a minefield of information to navigate. Time to make room at the table for Newsday's latest attempt to unravel the college chaos with their Essential Guide...

Continue Reading
Natura's 3Q26 Performance: Navigating Bottlenecks and Potential

Updated Category News Views 73

Unexpected Performance Amidst Challenging Circumstances I'll tell you, navigating through operational bottlenecks is no small feat, but Natura seems to be brewing its own survival recipe. They reported a net income of BRL 49 million in the third quarter of 2026, clawing back from a net loss of BRL 119 million in the previous year. That's no magic trick; it's a reflection...

Continue Reading
Curve Dental Pushes Dental Tech with New Marketing Head

Updated Category News Views 67

Curve Dental's Bold Move in Dental Technology Nat Harrison stepping up as Senior VP of Marketing at Curve Dental seems like a big swing for a firm already in the thick of reshaping dental practice management. Curve Dental's advancing platform boasts AI-powered, cloud-native capabilities that aim to streamline operations for dental teams stretched thin by daily demands....

Continue Reading
Vipshop Sets 2026 AGM: Shareholders Meet on Dec 8

Updated Category News Views 21

Blockbuster or Bust: Vipshop's Upcoming AGM Here's the scoop: Vipshop Holdings Limited, with its mammoth operations in China's off-price retail sector, is gearing up for its annual general meeting (AGM) on December 8, 2026. This is where management and stakeholders will hash out everything from strategic pivots to financial health. Forget shareholder votes this...

Continue Reading
Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Updated Category News Views 13

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Continue Reading
NYSE Gains Ground with Historic Listings Transfers

Updated Category News Views 69

You'll know it's a topsy-turvy market when hefty firms start switching their stock exchange allegiance. This year, nine noteworthy companies, with a collective market heft of nearly half a trillion dollars, kissed Nasdaq goodbye and nestled into the New York Stock Exchange (NYSE). Now, why would these big shots make the shift, you ask? Let's dive into the nitty-gritty....

Continue Reading
Kyndryl's Sovereignty Strategy Tackles Digital Resilience

Updated Category News Views 207

Driving Resilience Amidst Sovereignty Moves Hot off the press, Kyndryl is rolling out a beefed-up strategy to fortify operational resilience in the face of shifting digital sovereignty challenges. I’d say these guys got their fingers firmly on the geopolitical pulse, and they’re not messing around. “Maintaining critical IT operations is fundamental to business...

Continue Reading
Xavier Ochsner Opens State-of-the-Art Medical School

Updated Category News Views 57

A New Era for Medical Education in New Orleans If you're familiar with New Orleans, you know it's a city defined by its vibrancy, culture, and resilience. Well, the Xavier Ochsner College of Medicine is adding to that narrative with the opening of their spanking new Center for Medical Education. It's a project that promises to shake things up in the best possible way for...

Continue Reading
EDB Bolsters AI Governance With Strategic Expertise

Updated Category News Views 175

EDB’s Strategic Move in AI Governance EnterpriseDB (EDB) is throwing some serious weight behind their AI governance strategy by bringing in top-notch talent from CMRD. The buzz? This team didn’t just descend in a parachute—they already have their fingerprints all over the audit infrastructure of EDB’s governance solution. Now, they're officially joining EDB’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Fastenal Boosts Shareholder Value with $0.43 Dividend for 2025

Updated Category News Views 322

Fastenal Company Declaration of Dividend Fastenal Company (NASDAQ: FAST), a prominent distributor of industrial and construction supplies, has publicly announced a significant quarterly cash dividend of $0.43 per share. This dividend is set to be paid on February 28, 2025, to shareholders who are on record as of January 31, 2025. Notably, Fastenal has shown remarkable...

Continue Reading
Nokia Boosts Shareholder Value with Strategic Buyback Initiative

Updated Category News Views 160

Nokia Enhances Its Share Buyback Program Nokia Corporation (NYSE:NOK) recently took a significant step in its financial strategy by acquiring 872,093 of its own shares. This acquisition was completed at an average price of €4.38 per share, a move that underscores the company’s ongoing commitment to enhancing shareholder value. The buyback is part of a broader...

Continue Reading
Actum Welcomes Elevate Public Affairs to Boost Services

Updated Category News Views 242

Actum Expands Through Elevate Public Affairs Partnership Actum, a consulting firm skilled in navigating complex challenges, proudly announces the addition of Elevate Public Affairs to its dynamic team. This strategic move marks a significant enhancement in Actum's ability to deliver exceptional communication and advocacy services. Understanding Elevate Public Affairs...

Continue Reading
Atos Addresses Rumors of Ransomware Compromise by Space Bears

Updated Category News Views 167

Atos Addresses Ransomware Allegations from Space Bears Atos Group has recently made headlines, but not for reasons you'd expect. The company has officially confirmed that it has not been compromised by the notorious ransomware group known as Space Bears. This statement aims to clarify rumors surrounding the security of its digital infrastructure and reassure customers and...

Continue Reading
Ocean Casino Resort Welcomes Stephen Starr's New Dining Concepts

Updated Category News Views 245

Ocean Casino Resort Announces New Dining Experience Ocean Casino Resort has proudly announced an exciting new partnership with Stephen Starr, a celebrated restaurateur known nationwide for his innovative dining concepts. This collaboration will introduce two unique dining venues located on the lobby level of the resort, set to open this summer. With this initiative, Ocean...

Continue Reading